Long Covid Apheresis Community
Long Covid Apheresis Community
  • Home
  • Our Services
    • Community List
    • Our Reporting System
    • Success Rates&Reports
    • Resources For Doctors
    • Expert Interviews
    • Clinics List
  • Apheresis & Therapy FAQs
    • H.E.L.P. Apheresis FAQ
    • Combination Therapy FAQ
    • Forms of Apheresis FAQ
  • Research
  • Media
  • Microclots Tests
  • Types of Apheresis
  • Our Community Team
  • Contact
  • More
    • Home
    • Our Services
      • Community List
      • Our Reporting System
      • Success Rates&Reports
      • Resources For Doctors
      • Expert Interviews
      • Clinics List
    • Apheresis & Therapy FAQs
      • H.E.L.P. Apheresis FAQ
      • Combination Therapy FAQ
      • Forms of Apheresis FAQ
    • Research
    • Media
    • Microclots Tests
    • Types of Apheresis
    • Our Community Team
    • Contact
  • Home
  • Our Services
    • Community List
    • Our Reporting System
    • Success Rates&Reports
    • Resources For Doctors
    • Expert Interviews
    • Clinics List
  • Apheresis & Therapy FAQs
    • H.E.L.P. Apheresis FAQ
    • Combination Therapy FAQ
    • Forms of Apheresis FAQ
  • Research
  • Media
  • Microclots Tests
  • Types of Apheresis
  • Our Community Team
  • Contact

Treatment success rePORTS of Help Apheresis for Long Covid, Post Vac Syndrome and CI

H.E.L.P. Apheresis for Long Covid, Post Vac Syndrome and Chronic Illnesses/Post Viral Syndromes has shown outstanding success rates in the last years. Clinical experience has increased substantially since it's use was widely adapted by the medical community in Cyprus, Germany and Switzerland in 2021.  Small and large independent polls and reports of treating doctors demonstrated success rates between 70-90% (significant improvement) of the patients treated.  Published scientific studies show the same outcome of H.E.L.P. Apheresis for Long Covid and other similar conditions, please find the latest studies here


We are planning similar subpages as this one, as soon as we have received sufficient data on Immunopheresis, Plasmapheresis and subforms like Rheopheresis or Inuspheresis. Please find a comparison chart of apheresis forms used in LC, Post-Vac an CI here and a FAQ regarding various forms of apheresis here.

Sources with success rate reports on H.E.L.P. Apheresis for Long Covid, Post-Vac and CI:

ISFA 2023 World Congress (International Society for Apheresis)

 Dr. Gunnar J. Bücker, Dr. Marcella Bürkner, Dr. Lutz Fricke and Prof. Christel Weiß presented their Help Apheresis for Long Covid treatment results during the congress: 'The given findings show a high response rate with significant clinical improvements and long-lasting results. Thus, HELP seems to be a promising and safe treatment option for patients suffering from LC.'

abstract booklet

Results:

  • Comparison of symptoms before and after HELP shows a significant and sustained alleviation of symptoms (p < 0,0001) 
  • The overall rating increased from a score of 2 (range 1 – 3) before apheresis to 3 (1-5) after apheresis and to 4 (1.2-5) currently 
  • 83% of patients would recommend the treatment after they have been treated - Median treatment number: 5 treatments 
  • No worsening of symptoms after the treatment has been reported 
  • 1 in 144 treatments had sideffects (low bloodpressure) 

eureka health results

Eureka Health Polls (includes 35.000 treatments):

In this poll 35.000 treatment reports were included: https://twitter.com/EurekaHealthApp/status/1638345659144347651?s=20 

eureka health results

From the 35.000 treatment reports in the poll, H.E.L.P. Apheresis reached the 1st position of successful treatments with significant improvement for patients.

Additional Sources

- ISFA World Congress (International Society for Apheresis) -  Dr. Gunnar J. Bücker, Dr. Marcella Bürkner, Dr. Lutz Fricke and Prof. Christel Weiß presented their Help Apheresis for Long Covid treatment results during the congress: Comparison of symptoms before and after HELP shows a significant and sustained alleviation of symptoms (p < 0,0001), the overall rating increased from a score of 2 (range 1 – 3) before apheresis to 3 (1-5) after apheresis and to 4 (1.2-5) currently and 83% of patients would recommend the treatment after they have been treated
Page 62_63 with relevant data

Full ISFA2023 Booklet


- Eureka Health Poll - 35.000 treatment reports for Long Covid. H.E.L.P. Apheresis came in 1st position of successful treatments that improved patrients significantly: 

 https://twitter.com/EurekaHealthApp/status/1638345659144347651?s=20 


- Patient groups - over 75% of patients have benefited in various degrees  in polls of patient groups like 'Larnaca Helpers' or our own community group on  Facebook (see screenshot). 


- Public polls (Dr Trent Garrison/LongCovidPharm)  https://twitter.com/trentgarrison/status/1601743277346418688?s=20&t=nXvy6wU4sKKZ8cXlticO8Q 


- Treating Doctors Socials - Dr Gunnar Bücker on his twitter channel reports success rates of 60-80% https://mobile.twitter.com/buckergunnar


- Treating doctors in the Media - Dr Ringel  reports success rates of 70% in the media: 

https://www.focus.de/gesundheit/coronavirus/dialyse-arzt-ueber-blutwaesche-bei-long-covid-ich-bin-nicht-ganz-so-euphorisch_id_64318493.html


- Treating doctors in the Media - Dr Linkesch  reports success rates of 90% in the media: 

https://www.nzz.ch/wissenschaft/long-covid-ist-die-blutwaesche-therapie-nur-geschaeftemacherei-ld.1710589?reduced=true


- Dr Beate Jaeger in her observations reports success rates of 70-90%:

https://img1.wsimg.com/blobby/go/b2de8f6d-68eb-468a-af28-57cb2c7cc722/downloads/Jaeger%2007-04-2021_Long_Covid_Cases.pdf?ver=1667228472562

and 

https://www.youtube.com/watch?v=5RQZ-oVNwwM

76% of the patients treated at the Apheresis Center Larnaca, Cyprus improved after traetment

Poll in FB patient group (Larnaca Helpers) about treatment at the Apheresis Center Larnaca, Cyprus

https://twitter.com/trentgarrison/status/1601743277346418688?s=20&t=nXvy6wU4sKKZ8cXlticO8Q 
Picture: Poll by Dr. Trent Garrison (twitter)

In the poll by Dr Trent Garrison and LongCovidPharm H.E.L.P. Apheresis reached 1st place of all Non-pharmacological treatments. Sample size was not as large as in the Eureka poll though. 

Get on the community list for H.E.L.P Apheresis to receive available treatment slots and updates

 If you want to receive available treatment slots and newsletter updates, please register here (all our services are free, we are community built by volunteers/members for members): 

Get on the Community List for H.E.L.P Apheresis

JOIN OUR COMMUNITY:

Join our Facebook Group

Long Covid Apheresis Community

  • Privacy Policy

Get on our Community List!

All the Information and Help you need: 

Get on our community list to receive notifications about available treatment slots, latest updates and news first - expert interviews, research updates, patient and clinician insights and more.  It's free!

  (All our services are free, we are community built by volunteers/members for members)

Get on the Community List

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept